参考文献/References:
1 Heo DS.Progress and limitations in cancer gene therapy[J].Genet Med,2002,4(6 Suppl):52S-55S.
2 St George JA.Gene therapy progress and prospects:adenoviral vectors[J].Gene Ther,2003,10(14):1135-1141.
3 Springer CJ,Niculescu-Duvazl I.Prodrug activating systems in suicide gene therapy[J].J Clin Inves,2000,105(9):1161-1167.
4 Lundstrom K.Latest development in viral vectors for gene therapy[J].Trends Biotechnol,2003,21(3):117-122.
5 Romano G,Pacilio C,Giordano A.Gene transfer technology in the rapy:current applications and future goals[J].Stem Cells,1999,17(4):191-202.
6 DONG Wen-ji,ZU Zhen-xiang,LIU De-pei,et al.Development ofgene therapy for hematopoietic stem cell using viral vectors[J].ActaGenetica Sinica,2003,30(4):382-388.
7 Buller RE,Runnebaum IB,Karlan BY,et al.A phase I/II trial ofrAd/p53(SCH58500) gene replacement in recurrent ovarian cancer[J].Cancer Gene Ther,2002,9(7):553-566.
8 Fukuda Y,Yamamura J,Uwano T,et al.Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vector[J].Neurosci Res,2003,45(2):233-241
9 Park J,Ries J,Gelse K,et al.Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer:a comparison of adeno viral vectors and liposomes[J].Gene Ther,2003,10(13):1089-1098.
10 Ramesh R,Saeki T,Templeton NS,et al.Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector[J].Mol Ther,2001,3(3):337-350.
11 Kaiser J.Gene therapy.RAC’s advice:proceed with caution[J].Science,2002,298(5601):2113-2115.
12 Kaiser J.Gene therapy.Seeking the cause of induced leukemias in X-SCID trial[J].Science,2003,299(5606):495.
13 Marshall E.Clinical research.Gene therapy a suspect in leukemia-liked disease[J].Science,2002,298(5591):34-35.
14 Check E.Safety panel backs principle of gene therapy trials[J].Nature,2002,420(6916):595.
15 Richard JC,Factor P,Welch LC,et al.Imaging the spatial distribution of transgene expression in the lungs with positron emission tomography[J].Gene Ther,2003,10(25):2074-2080.
16 Umegaki H,Ishiwata K,Ogawa O,et al.Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine D2 receptors in the striatum in young,middle-aged,and aged rats:a positron emission tomography study[J].Neuroscience,2003,121(02):479-486.
17 Rogers BE,Chaudhuri TR,Reynolds PN,et al.Non-invasive gamma camera imaging of gene transfer using an adenoviral vectorencodingan epitope-tagged receptor as a reporter[J].Gene Ther,2003,10(2):105-114.
18 Dewanjee MK,Ghafouripour AK,Kapadvanjwala M,et al.Noninva-sive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model[J].J Nucl Med,1994,35(6):1054-1063.
19 Mairs R J,Cunningham SH,Boyd M,et al.Application of gene transfer to targeted radiotherapy[J].Curr Pharm Des,2000,6(14):1419-1432.
20 Buchsbaum DJ.Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs[J].Semin Nucl Med,2004,34(1):32-46.
21 Rogers BE,Zinn KR,Buchsbaum DJ.Gene transfer strategies for improving radiolabeled peptide imaging and therapy[J].Q J Nucl Med,2000,44(3):208-223.
22 Rosenfeld ME,Rogers BE,Khazaeli MB,et al.Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo[J].Clin Cancer Res,1997,3(7):1187-1194.
23 Celinski SA,Fisher WE,Amaya F,et al.Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts[J].J Surg Res,2003,115(1):41-47.
24 Boland A,Magnon C,Filetti S,et al.Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers[J].Thyroid,2002,12(1):19-26.
25 Watanabe N,Sawai H,Endo K,et al.Labeling of phosphorothioate antisense oligonucleotides with yttrium-90[J].Nucl Med Biol,1999,26(2):239-243.